Who owns BOLT BIOTHERAPEUTICS INC?
- Ticker: BOLT
- CUSIP Number: 097702104
Tip: Access positions for across all investors
Analyze quarterly positions in Bolt Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bolt Biotherapeutics stock
Who bought or sold BOLT BIOTHERAPEUTICS INC this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| Tang Capital Management | 3.8M | $2.0M | 0% | Dec 2024 |
|
| Vivo Capital | 3.5M | $1.9M | 0% | Dec 2024 |
|
| Sofinnova Ventures | 2.8M | $1.5M | 0% | Dec 2024 |
|
| Pivotal bioVenture Partners Investment Advisor | 1.9M | $1.0M | 0% | Dec 2024 |
|
| Nan Fung Group Holdings | 1.2M | $624k | 0% | Dec 2024 |
|
| Vanguard Group | 1.1M | $571k | 0% | Dec 2024 |
|
| Samsara BioCapital | 1.0M | $561k | 0% | Dec 2024 |
|
| Board of Trustees of The Leland Stanford Junior University | 720k | $385k | 0% | Dec 2024 |
|
| Geode Capital Management | 341k | $182k | -3% | Dec 2024 |
|
| Renaissance Technologies | 302k | $162k | 3% | Dec 2024 |
|
| BlackRock | 270k | $145k | 0% | Dec 2024 |
|
| ADAR1 Capital Management | 245k | $131k | 0% | Dec 2024 |
|
| FMR | 129k | $69k | 12% | Dec 2024 |
|
| Citadel Advisors | 79k | $42k | 100% | Dec 2024 |
|
| Engineers Gate Manager | 72k | $39k | 100% | Dec 2024 |
|
| UBS Group | 66k | $35k | 87% | Dec 2024 |
|
| Bridgeway Capital Management | 60k | $32k | 0% | Dec 2024 |
|
| Goldman Sachs Group | 50k | $27k | 100% | Dec 2024 |
|
| Velan Capital Investment Management | 50k | $27k | 100% | Dec 2024 |
|
| Squarepoint Ops | 49k | $26k | 100% | Dec 2024 |
|
| State Street Corporation | 47k | $25k | 0% | Dec 2024 |
|
| Millennium Management | 47k | $25k | 100% | Dec 2024 |
|
| XTX Topco | 45k | $24k | 100% | Dec 2024 |
|
| Jane Street | 42k | $22k | 49% | Dec 2024 |
|
| Northern Trust | 41k | $22k | 0% | Dec 2024 |
|
| Mariner Wealth Advisors | 35k | $19k | -14% | Dec 2024 |
|
| Virtu Financial | 30k | $16k | 100% | Dec 2024 |
|
| Advisor Group Holdings | 17k | $11k | 0% | Dec 2024 |
|
| Morgan Stanley | 12k | $12k | -50% | Dec 2024 |
|
| Bank of America Corporation | 5.6k | $3.0k | -6% | Dec 2024 |
|
| Tower Research Capital | 4.0k | $2.1k | 2078% | Dec 2024 |
|
| Jpmorgan Chase & Co | 911.00 | $487.567200 | 0% | Dec 2024 |
|
| SBI Securities | 200.00 | $107.000000 | 100% | Dec 2024 |
|
| Barclays | 139.00 | $0 | 0% | Dec 2024 |
|
| Salem Investment Counselors | 40.00 | $16.000000 | 0% | Mar 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.00 | $1.000000 | 100% | Dec 2024 |
|
Who sold out of Bolt Biotherapeutics?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
|---|---|---|---|
| Adage Capital Partners GP | Sep 2024 | 500k | $324k |
| Newtyn Management | Sep 2024 | 469k | $304k |
| Susquehanna International | Sep 2024 | 148k | $96k |
| Prudential Financial | Sep 2024 | 59k | $38k |
| Two Sigma Securities | Sep 2024 | 26k | $17k |
| Assenagon Asset Management | Dec 2024 | 21k | $11k |